Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...

SHANGHAI, May 29, 2025 /PRNewswire/ -- The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan, China's first domestically developed antibody-drug ...

Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., Warsaw 03-195, Poland Centre of Radiochemistry and Nuclear Chemistry, Institute of ...

Objective: To analyze the prognosis of patients with breast cancer who developed trastuzumab-induced cardiotoxicity and to analyze factors associated with and resulting from cardiotoxicity. Methods: ...

She received postoperative adjuvant radiotherapy, chemotherapy (including paclitaxel and capecitabine), and anti-HER2 targeted therapy (trastuzumab, pertuzumab, pyrotinib, T-DM1 [ado-trastuzumab ...